Phaos Technology Holdings (Cayman) (POAS) Total Non-Current Liabilities (2024 - 2025)
Phaos Technology Holdings (Cayman) (POAS) posted Total Non-Current Liabilities of $59814.0 for Q4 2025, down 20.89% on a QoQ basis from $75610.0 in Q2 2025.
Phaos Technology Holdings (Cayman) (POAS) Total Non-Current Liabilities (2024 - 2025) Analysis & Trends
Phaos Technology Holdings (Cayman)'s Total Non-Current Liabilities history runs 2 years deep, the most recent figure standing at $59814.0 for Q4 2025.
- Quarterly Total Non-Current Liabilities changed N/A year-over-year to $59814.0 in Q4 2025, while the trailing twelve-month figure through Oct 2025 was $59814.0 (changed N/A YoY) and the FY2025 annual result came in at $75679.3, down 53.53% from the prior year.
- Total Non-Current Liabilities was $59814.0 for Q4 2025 at Phaos Technology Holdings (Cayman), down from $75610.0 in the prior quarter.
- Across five years, Total Non-Current Liabilities topped out at $162855.3 in Q2 2024 and bottomed at $59814.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.06 Bn | 175.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.66 Bn | 125.78 Bn | 3.81 Bn | 20.94 Bn |
| 3 | Medtronic | 108.82 Bn | 99.60 Bn | 6.41 Bn | 41.44 Bn |
| 4 | Boston Scientific | 68.43 Bn | 66.98 Bn | 3.61 Bn | 41.88 Bn |
| 5 | Edwards Lifesciences | 48.29 Bn | 44.61 Bn | 1.29 Bn | 2.64 Bn |
| 6 | GE HealthCare Technologies | 28.37 Bn | 26.08 Bn | 1.98 Bn | 24.21 Bn |
| 7 | Dexcom | 28.29 Bn | 27.18 Bn | 750.30 Mn | 3.53 Bn |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - | 3.57 Bn |
| 9 | Koninklijke Philips | 25.43 Bn | 22.31 Bn | 2.07 Bn | 9.85 Bn |
| 10 | Phaos Technology Holdings (Cayman) | 6.17 Mn | 6.12 Mn | - | 59,814.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2025 | 59,814.00 |
| Apr 30, 2025 | 75,610.04 |
| Apr 30, 2024 | 162,855.32 |